Identification of DksA as a novel pro-inflammatory mediator of <i>Pseudomonas aeruginosa</i> under conditions mimicking chronic cystic fibrosis lung infection.
DksA has been identified as a novel mediator of inflammation in Pseudomonas aeruginosa infections associated with cystic fibrosis, but the clinical implications remain unclear due to a lack of quantitative data.
Where it sits
this study against the rest of the 5-amino-1mq corpusSummary and findings
This study aimed to identify bacterial mediators sustaining persistent inflammation in chronic infections with Pseudomonas aeruginosa in cystic fibrosis patients. The researchers analyzed clinical isolates and found variability in pro-inflammatory activity, identifying DksA as a significant immunomodulatory mediator. The findings suggest a novel role for DksA in contributing to airway inflammation in cystic fibrosis.
Abstract
Chronic infection with <i>Pseudomonas aeruginosa</i> is a major driver of airway inflammation, which plays a central role in the progression of cystic fibrosis (CF) lung disease. During long-term colonization, <i>P. aeruginosa</i> adapts to the CF lung by downregulating virulence factors and adopting a biofilm-associated, mucoid lifestyle. Despite the expected reduction in immune activation due to these adaptations, excessive inflammation persists, a paradox that remains poorly understood. Our objective was to identify novel bacterial mediators sustaining persistent inflammation by <i>P. aeruginosa</i> in the CF lung. To this end, we analyzed clinical <i>P. aeruginosa</i> CF isolates, cultured them in synthetic CF sputum medium, and exposed 3D lung epithelial cell cultures to the resulting cell-free supernatants. There was considerable variability in pro-inflammatory activity among the isolates, with a subset of the isolates inducing strong IL-8 secretion by the 3D cells despite low production of known virulence factors. Comparative proteomics analysis of the cell-free supernatants of pro-inflammatory and immunosuppressive isolates revealed several mediators not previously linked to inflammation. Thirteen of these candidate pro-inflammatory mediators were selected for further analysis. Using <i>P. aeruginosa</i> transposon mutants lacking the respective mediators, DksA (a transcription factor) was confirmed as an immunomodulatory mediator in the 3D lung model. Finally, analysis of existing transcriptomes of <i>P. aeruginosa</i> in CF sputum revealed that <i>dksA</i> was found to be one of the most strongly expressed genes in this patient population, highlighting the relevance of our findings. In conclusion, we identified a novel <i>P. aeruginosa</i> mediator that may contribute to CF airway inflammation.
Background
Chronic infection with Pseudomonas aeruginosa is a significant factor in airway inflammation associated with cystic fibrosis (CF) lung disease. Previous research has shown that during long-term colonization, P. aeruginosa adapts by downregulating virulence factors, yet excessive inflammation continues, creating a paradox. This study addresses the gap in understanding the mediators of persistent inflammation in the CF lung, which is crucial for developing potential therapeutic strategies.
Methods
The study involved analyzing clinical Pseudomonas aeruginosa CF isolates cultured in synthetic CF sputum medium. The researchers exposed 3D lung epithelial cell cultures to the resulting cell-free supernatants to assess pro-inflammatory activity. Comparative proteomics analysis was conducted on the supernatants of pro-inflammatory and immunosuppressive isolates, leading to the identification of several novel mediators.
Results
The study found considerable variability in pro-inflammatory activity among the isolates, with some inducing strong IL-8 secretion despite low production of known virulence factors. DksA was confirmed as an immunomodulatory mediator through the use of Pseudomonas aeruginosa transposon mutants.
Interpretation
The identification of DksA as a pro-inflammatory mediator adds to the understanding of how Pseudomonas aeruginosa contributes to inflammation in cystic fibrosis. While the findings are significant, the abstract does not provide specific statistical analyses or effect sizes, making it difficult to evaluate the clinical relevance of these results fully. The study's limitations include a lack of quantitative data and potential confounding factors related to the variability of isolates.
Key findings
- DksA was confirmed as an immunomodulatory mediator in the 3D lung model.
- Thirteen candidate pro-inflammatory mediators were selected for further analysis.
- DksA was one of the most strongly expressed genes in existing transcriptomes of Pseudomonas aeruginosa in CF sputum.
Limitations
- Not reported in abstract.
- No specific quantitative measures or statistical analyses provided.
- Potential variability in pro-inflammatory activity among isolates not quantified.